<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01746121</url>
  </required_header>
  <id_info>
    <org_study_id>4266</org_study_id>
    <nct_id>NCT01746121</nct_id>
  </id_info>
  <brief_title>Amelogenesis Imperfecta</brief_title>
  <official_title>Clinical and Molecular Study of Amelogenesis Imperfecta</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Amelogenesis Imperfecta (AI) are a heterogeneous group of rare genetic diseases transmitted
      according to various mode of inheritance (X-linked, autosomal dominant, autosomal recessive)
      affecting the formation/mineralization of tooth enamel. These diseases exist in isolation
      with clinical manifestations limited to the oral cavity or may be associated to other
      symptoms in syndromes. Many different genes (AMELX, ENAM, ENAMELYSIN or MMP20, KLK4, DLX3,
      FAM83H, FAM20A WDR72…) coding for enamel matrix proteins, enamel matrix degrading proteins,
      proteins involved in hydroxyapatite formation and growth and mineralization processes have
      been discovered responsible for the clinical phenotypes (hypoplastic, hypomineralized,
      hypomature) encountered in AI.

      Genes involved in enamel formation but not yet identified in association with any form of AI
      include: AMELY, AMELOBLASTIN, TUFTELIN, AMELOTIN, A Pin protein, ODAM (Odontogenic ameloblast
      associated).

      In this research protocol the investigators explore the phenotype including the enamel
      ultrastructure and the genotype of a cohort of patients presenting AI.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>November 2009</start_date>
  <primary_completion_date type="Anticipated">March 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Family-Based</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Natural history of Amelogenesis Imperfecta</measure>
    <time_frame>at day of enrollment</time_frame>
    <description>Familial, medical, dental history</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Phenotype of Amelogenesis Imperfecta</measure>
    <time_frame>at day of enrollment</time_frame>
    <description>Clinical and radiographic examination Type of enamel defects Associated dental or craniofacial anomalies</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Genetic Bases of Amelogenesis Imperfecta</measure>
    <time_frame>within 3 years after enrollment</time_frame>
    <description>Genetic analysis</description>
  </other_outcome>
  <other_outcome>
    <measure>Ultrastructure of teeth hard tissues</measure>
    <time_frame>within 3 years after enrollment</time_frame>
    <description>Ultrastructure analysis of teeth hard tissues</description>
  </other_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">600</enrollment>
  <condition>Amelogenesis Imperfecta</condition>
  <arm_group>
    <arm_group_label>Amelogenesis Imperfecta</arm_group_label>
    <description>Salivary and blood sampling, as part of routine care. Collection of exfoliated teeth</description>
  </arm_group>
  <arm_group>
    <arm_group_label>healthy family members</arm_group_label>
    <description>Salivary and blood sampling, as part of routine care. Collection of exfoliated teeth</description>
  </arm_group>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>Salivary and blood sampling, as part of routine care. Collection of exfoliated teeth.</intervention_name>
    <arm_group_label>Amelogenesis Imperfecta</arm_group_label>
    <arm_group_label>healthy family members</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      saliva
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        The recruitment of patients comes from several sources. A first cohort of 40 families is
        already followed by the reference center of Strasbourg. The reference center for rare
        diseases dental manifestations of Strasbourg recruiting patients at regional,
        interregional, national and international scale.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria:

          -  Patient presenting with AI

          -  New patient or patient already known in the center

          -  Child (in his primary dentition) or adult

          -  Man or woman

          -  Having signed a consent form or accepted to participate to the study

          -  Patient affiliated to social security

          -  Validation of the inclusion by the principal investigator looking at the patient file

        Exclusion criteria:

          -  Patient with acquired enamel defects

          -  Patient whose clinical diagnostic is not possible

          -  Patient whose clinical file does not contain teeth photos

          -  Patient who has not signed a consent form and accepted to participate to the study

          -  Patient who is not affiliated to social security.

          -  Non validation of the inclusion by the principal investigator looking at the patient
             file
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bloch-Zupan Agnes, DChD, PhD, HDR, PU-PH</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital of Strasbourg</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Agnès BLOCH-ZUPAN, PUPH</last_name>
    <phone>03 88 11 69 10</phone>
    <email>agnes.bloch-zupan@unistra.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hôpitaux Universitaires de Strasbourg</name>
      <address>
        <city>Strasbourg</city>
        <state>Alsace</state>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Hélène DOLLFUS, PUPH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Béatrice RICHARD, MCUPH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>D. LACOMBE, PUPH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Corinne TARDIEU, PUPH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nicole PHILIP, PUPH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jean Louis SIXOU, PUPH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>S. ODENT, PUPH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jean Jacques MORRIER, PUPH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marie-Monique ROUSSET, PUPH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>S. MANOUVRIER-HANU, PUPH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marie-Cécile MANIERE, PUPH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>William BACON, PUPH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Matthieu SCHMITTBUHL, PUPH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Fréderic OBRY, MCUPH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Etienne WALTMANN, MCUPH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>François CLAUSS, PUPH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Annelyse GARRET, AH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jean-Christophe FARGES, PUPH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jean Pierre DUPREZ, MCUPH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Béatrice TIHVICHON-PRINCE, AHU</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Benoît LEHEIS, AHU</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Caroline DELFOSSE, MCUPH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Joel FERRI, PUPH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 22, 2012</study_first_submitted>
  <study_first_submitted_qc>December 6, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 10, 2012</study_first_posted>
  <last_update_submitted>February 4, 2013</last_update_submitted>
  <last_update_submitted_qc>February 4, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 5, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Amelogenesis Imperfecta</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

